logo

For the Inventor, By the Inventor

Oberrohrbach, Austria

Walter Spevak

This inventor holds 16 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Gmbh & Co Kg, Boehringer Ingelheim Pharma Kg. Active years: 1993-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Walter Spevak. Retrieved from https://idiyas.com/inventor/walter-spevak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16

% Patents Active = 93.8



Average Co-Inventor Count = 8.2

ph-index = 6

Forward Citations = 219(Granted Patents)


Location History:

  • Stockerau, AT (1993 - 1997)
  • Oberronhrbach, AT (2007)
  • Oberrohrbach, AT (2003 - 2014)

Company Filing History:

goldMedal6 out of 1,564 
 
Boehringer Ingelheim International Gmbh
 patents
silverMedal6 out of 194 
 
Boehringer Ingelheim Pharma Gmbh & Co Kg
 patents
bronzeMedal3 out of 149 
 
Boehringer Ingelheim Pharma Kg
 patents
4. 3 out of 278 
 
Boehringer Ingelheim Pharmaceuticals, Inc.
 patents
5. 1 out of 6 
 
Boehringer Ingelheim Zentrale
 patents
where one patent can have more than one assignee

Years Active: 1993-2014

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
6-Alkynylpyridines
Pyrimidine Derivatives
Chemical Compounds
Substituted Indolinones
Pharmaceutical Compositions
Inhibitory Effect
Kinases
Receptor Tyrosine Kinases
Human Lysozyme
Manganese Superoxide Dismutase
Medicaments
Preparation Methods
16 patents (USPTO):Explore Patents
1. 8859541 - 6-alkynylpyridines (2014-10-14),
2. 8420630 - Pyrimidine derivatives (2013-04-16),
3. 8203001 - Chemical compounds (2012-06-19),
4. 7709480 - Pyrimidine derivatives (2010-05-04),
5. 7173028 - Pyrimidine derivatives (2007-02-06),
6. 7166615 - Substituted indolinones, preparation thereof and their use as pharmaceutical compositions (2007-01-23),
7. 7160901 - Substituted indolinones, preparation thereof and their use as pharmaceutical compositions (2007-01-09),
8. 6855710 - Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs (2005-02-15),
9. 6794395 - Substituted indolinones, their manufacture and their use as medicaments (2004-09-21),
10. 6762180 - Substituted indolines which inhibit receptor tyrosine kinases (2004-07-13),
11. 6638965 - Substituted indolinones, preparation thereof and their use as pharmaceutical compositions (2003-10-28),
12. 5618712 - Human lysozyme (1997-04-08),
13. 5589371 - Human manganese superoxide dismutase (hMn-SOD) (1996-12-31),
14. 5436162 - Human manganese superoxide dismutase (hMn-SOD) (1995-07-25),
15. 5260204 - Human manganese superoxide dismutase (hMn-SOD) (1993-11-09),

Title: The Innovations of Walter Spevak: Pioneering Medicinal Chemistry

Introduction

Walter Spevak, an accomplished inventor hailing from Oberrohrbach, Austria, has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 16 patents, Spevak's work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest inventions, Spevak has developed 6-alkynylpyridines, which are known as SMAC mimetics. These compounds are particularly noteworthy for their utility as medicaments in the treatment of diseases characterized by excessive or abnormal cell proliferation, including various forms of cancer. Additionally, he has contributed to the development of pyrimidine derivatives, specifically trisubstituted pyrimidines, which represent a significant leap in the quest for effective treatments.

Career Highlights

Throughout his career, Walter Spevak has been affiliated with notable organizations such as Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim International GmbH. His dedication to advancing pharmaceutical science has led to numerous innovations that continue to shape medicinal research and development.

Collaborations

Spevak has collaborated with esteemed colleagues, including Martin Lenter and Gerald Juergen Roth. These collaborations have further enriched his research, allowing for the exchange of ideas and expertise that enhance the quality of his inventions.

Conclusion

Walter Spevak stands out as a prominent inventor in the field of medicinal chemistry. With his innovative approach and numerous patents, he continues to make strides in developing groundbreaking therapies that address critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…